↓ Skip to main content

CB1 Cannabinoid Receptor is a Target for Neuroprotection in Light Induced Retinal Degeneration

Overview of attention for article published in Advances in Drug and Alcohol Research, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CB1 Cannabinoid Receptor is a Target for Neuroprotection in Light Induced Retinal Degeneration
Published in
Advances in Drug and Alcohol Research, September 2022
DOI 10.3389/adar.2022.10734
Pubmed ID
Authors

Manuel Soliño, Ignacio M. Larrayoz, Ester María López, Manuel Rey-Funes, Mariana Bareiro, Cesar Fabián Loidl, Elena Girardi, Laura Caltana, Alicia Brusco, Alfredo Martínez, Juan José López-Costa

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 100%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 50%
Veterinary Science and Veterinary Medicine 1 25%
Medicine and Dentistry 1 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2022.
All research outputs
#16,697,972
of 24,558,777 outputs
Outputs from Advances in Drug and Alcohol Research
#17
of 27 outputs
Outputs of similar age
#245,263
of 423,318 outputs
Outputs of similar age from Advances in Drug and Alcohol Research
#1
of 1 outputs
Altmetric has tracked 24,558,777 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 27 research outputs from this source. They receive a mean Attention Score of 2.5. This one scored the same or higher as 10 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,318 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them